THALIDOMIDE REVISITED

被引:1
作者
DARCY, PF [1 ]
GRIFFIN, JP [1 ]
机构
[1] ASSOC BRITISH PHARMACEUT IND,LONDON,ENGLAND
来源
ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS | 1994年 / 13卷 / 02期
关键词
THALIDOMIDE; HYPOTHYROIDISM; PERIPHERAL NEUROPATHY; FETAL TOXICITY AND TERATOGENICITY; NEW INDICATIONS LEPRA REACTION; BEHCETS SYNDROME; OROPHARYNGEAL ULCERATION; AIDS; BONE MARROW TRANSPLANTATION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:65 / 76
页数:12
相关论文
共 61 条
[21]  
IYER CGS, 1971, B WORLD HEALTH ORGAN, V45, P719
[22]  
Jadhav V H, 1990, Indian J Lepr, V62, P316
[23]  
JENKINS JS, 1984, LANCET, V2, P1424
[24]  
JENKINS S, 1985, LANCET, V1, P511
[25]  
KUNZ W, 1956, ARZNEIMITTEL-FORSCH, V6, P426
[26]  
LEHNER T, 1985, LANCET, V1, P288
[27]  
LILLICRAP DA, 1962, BMJ-BRIT MED J, V1, P477
[28]  
LIM SH, 1988, LANCET, V1, P117
[29]   THALIDOMIDE INHIBITS THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
MAKONKAWKEYOON, S ;
LIMSONPOBRE, RNR ;
MOREIRA, AL ;
SCHAUF, V ;
KAPLAN, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :5974-5978
[30]   THALIDOMIDE IN THE TREATMENT OF RECURRENT, NECROTIC, AND GIANT MUCOCUTANEOUS APHTHAE AND APHTHOSIS [J].
MASCARO, JM ;
LECHA, M ;
TORRAS, H .
ARCHIVES OF DERMATOLOGY, 1979, 115 (05) :636-637